Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_assertion type Assertion NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_head.
- NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_assertion description "[In a patient who had metastatic anaplastic lymphoma kinase (ALK)-rearranged lung cancer, resistance to crizotinib developed because of a mutation in the ALK kinase domain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_provenance.
- NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_assertion evidence source_evidence_literature NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_provenance.
- NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_assertion SIO_000772 26698910 NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_provenance.
- NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_assertion wasDerivedFrom befree-2016 NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_provenance.
- NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_assertion wasGeneratedBy ECO_0000203 NP1295825.RAwaamp54ksn_0LqyX-POMWXoEx_TJ6NIuOVdzdITbbAM130_provenance.